nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—germ cell cancer—thyroid cancer	0.791	1	CtDrD
Bleomycin—LIG3—Resolution of AP sites via the single-nucleotide replacement pathway—SMUG1—thyroid cancer	0.0155	0.258	CbGpPWpGaD
Bleomycin—Radiation pneumonitis—Sorafenib—thyroid cancer	0.0144	0.154	CcSEcCtD
Bleomycin—LIG3—Base Excision Repair—SMUG1—thyroid cancer	0.0107	0.179	CbGpPWpGaD
Bleomycin—BLMH—saliva-secreting gland—thyroid cancer	0.00677	0.138	CbGeAlD
Bleomycin—LIG3—thyroid gland—thyroid cancer	0.00553	0.113	CbGeAlD
Bleomycin—BLMH—trachea—thyroid cancer	0.00522	0.106	CbGeAlD
Bleomycin—LIG1—thyroid gland—thyroid cancer	0.00512	0.104	CbGeAlD
Bleomycin—LIG3—head—thyroid cancer	0.0049	0.1	CbGeAlD
Bleomycin—LIG1—Removal of DNA patch containing abasic residue—SMUG1—thyroid cancer	0.00456	0.0757	CbGpPWpGaD
Bleomycin—LIG1—head—thyroid cancer	0.00454	0.0925	CbGeAlD
Bleomycin—LIG1—Base Excision Repair—SMUG1—thyroid cancer	0.00417	0.0693	CbGpPWpGaD
Bleomycin—BLMH—thyroid gland—thyroid cancer	0.00413	0.0842	CbGeAlD
Bleomycin—BLMH—head—thyroid cancer	0.00367	0.0747	CbGeAlD
Bleomycin—Hyperkeratosis—Sorafenib—thyroid cancer	0.00364	0.0388	CcSEcCtD
Bleomycin—LIG3—lymph node—thyroid cancer	0.00343	0.07	CbGeAlD
Bleomycin—LIG1—lymph node—thyroid cancer	0.00318	0.0648	CbGeAlD
Bleomycin—Mucosal inflammation—Vandetanib—thyroid cancer	0.00279	0.0297	CcSEcCtD
Bleomycin—LIG3—DNA Repair—SMUG1—thyroid cancer	0.00258	0.0429	CbGpPWpGaD
Bleomycin—BLMH—lymph node—thyroid cancer	0.00257	0.0523	CbGeAlD
Bleomycin—Hypomagnesaemia—Vandetanib—thyroid cancer	0.00243	0.0258	CcSEcCtD
Bleomycin—Nail disorder—Vandetanib—thyroid cancer	0.00238	0.0253	CcSEcCtD
Bleomycin—Interstitial lung disease—Vandetanib—thyroid cancer	0.00218	0.0232	CcSEcCtD
Bleomycin—LIG1—Extension of Telomeres—TERT—thyroid cancer	0.00207	0.0344	CbGpPWpGaD
Bleomycin—Cystitis haemorrhagic—Epirubicin—thyroid cancer	0.00192	0.0204	CcSEcCtD
Bleomycin—Mucosal inflammation—Sorafenib—thyroid cancer	0.00188	0.02	CcSEcCtD
Bleomycin—LIG1—Erlotinib—Vandetanib—thyroid cancer	0.00181	0.316	CbGdCrCtD
Bleomycin—Cystitis haemorrhagic—Doxorubicin—thyroid cancer	0.00177	0.0189	CcSEcCtD
Bleomycin—BLMH—Afatinib—Vandetanib—thyroid cancer	0.00171	0.297	CbGdCrCtD
Bleomycin—Cystitis noninfective—Vandetanib—thyroid cancer	0.00151	0.016	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—RAP1GAP—thyroid cancer	0.00149	0.0248	CbGpPWpGaD
Bleomycin—Cystitis—Vandetanib—thyroid cancer	0.00149	0.0159	CcSEcCtD
Bleomycin—Interstitial lung disease—Sorafenib—thyroid cancer	0.00147	0.0156	CcSEcCtD
Bleomycin—Bladder pain—Vandetanib—thyroid cancer	0.00139	0.0148	CcSEcCtD
Bleomycin—LIG1—HIV Life Cycle—TPR—thyroid cancer	0.00123	0.0205	CbGpPWpGaD
Bleomycin—LIG1—Afatinib—Vandetanib—thyroid cancer	0.00119	0.207	CbGdCrCtD
Bleomycin—LIG1—Gefitinib—Vandetanib—thyroid cancer	0.00104	0.181	CbGdCrCtD
Bleomycin—LIG1—DNA Repair—SMUG1—thyroid cancer	0.001	0.0166	CbGpPWpGaD
Bleomycin—Skin exfoliation—Sorafenib—thyroid cancer	0.000993	0.0106	CcSEcCtD
Bleomycin—Bronchospasm—Vandetanib—thyroid cancer	0.000952	0.0101	CcSEcCtD
Bleomycin—LIG1—Telomere Maintenance—TERT—thyroid cancer	0.00094	0.0156	CbGpPWpGaD
Bleomycin—BLMH—Immune System—RAP1GAP—thyroid cancer	0.000904	0.015	CbGpPWpGaD
Bleomycin—Weight decreased—Vandetanib—thyroid cancer	0.000875	0.00932	CcSEcCtD
Bleomycin—Pneumonia—Vandetanib—thyroid cancer	0.000868	0.00924	CcSEcCtD
Bleomycin—LIG1—HIV Infection—TPR—thyroid cancer	0.000852	0.0141	CbGpPWpGaD
Bleomycin—Stomatitis—Vandetanib—thyroid cancer	0.000841	0.00895	CcSEcCtD
Bleomycin—Haematuria—Vandetanib—thyroid cancer	0.000823	0.00876	CcSEcCtD
Bleomycin—Myelosuppression—Epirubicin—thyroid cancer	0.00082	0.00873	CcSEcCtD
Bleomycin—LIG1—Chromosome Maintenance—TERT—thyroid cancer	0.000783	0.013	CbGpPWpGaD
Bleomycin—Haemoglobin—Vandetanib—thyroid cancer	0.000778	0.00829	CcSEcCtD
Bleomycin—Haemorrhage—Vandetanib—thyroid cancer	0.000774	0.00824	CcSEcCtD
Bleomycin—Myelosuppression—Doxorubicin—thyroid cancer	0.000759	0.00808	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000745	0.0124	CbGpPWpGaD
Bleomycin—Local reaction—Epirubicin—thyroid cancer	0.000694	0.00739	CcSEcCtD
Bleomycin—Mucosal inflammation—Epirubicin—thyroid cancer	0.000694	0.00739	CcSEcCtD
Bleomycin—Alopecia—Vandetanib—thyroid cancer	0.000684	0.00728	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—PCM1—thyroid cancer	0.000666	0.0111	CbGpPWpGaD
Bleomycin—Skin hyperpigmentation—Epirubicin—thyroid cancer	0.000646	0.00688	CcSEcCtD
Bleomycin—Mucosal inflammation—Doxorubicin—thyroid cancer	0.000642	0.00684	CcSEcCtD
Bleomycin—Local reaction—Doxorubicin—thyroid cancer	0.000642	0.00684	CcSEcCtD
Bleomycin—Febrile neutropenia—Epirubicin—thyroid cancer	0.000639	0.0068	CcSEcCtD
Bleomycin—Hypomagnesaemia—Epirubicin—thyroid cancer	0.000605	0.00644	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Doxorubicin—thyroid cancer	0.000598	0.00637	CcSEcCtD
Bleomycin—Nail disorder—Epirubicin—thyroid cancer	0.000593	0.00631	CcSEcCtD
Bleomycin—Febrile neutropenia—Doxorubicin—thyroid cancer	0.000591	0.00629	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000591	0.00982	CbGpPWpGaD
Bleomycin—Weight decreased—Sorafenib—thyroid cancer	0.00059	0.00629	CcSEcCtD
Bleomycin—Cough—Vandetanib—thyroid cancer	0.000588	0.00626	CcSEcCtD
Bleomycin—Pneumonia—Sorafenib—thyroid cancer	0.000585	0.00623	CcSEcCtD
Bleomycin—Chest pain—Vandetanib—thyroid cancer	0.000574	0.00611	CcSEcCtD
Bleomycin—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000574	0.00611	CcSEcCtD
Bleomycin—Myocardial infarction—Sorafenib—thyroid cancer	0.00057	0.00607	CcSEcCtD
Bleomycin—Stomatitis—Sorafenib—thyroid cancer	0.000567	0.00604	CcSEcCtD
Bleomycin—Hypomagnesaemia—Doxorubicin—thyroid cancer	0.00056	0.00596	CcSEcCtD
Bleomycin—Oedema—Vandetanib—thyroid cancer	0.00055	0.00586	CcSEcCtD
Bleomycin—Nail disorder—Doxorubicin—thyroid cancer	0.000548	0.00584	CcSEcCtD
Bleomycin—Infection—Vandetanib—thyroid cancer	0.000547	0.00582	CcSEcCtD
Bleomycin—Thrombocytopenia—Vandetanib—thyroid cancer	0.000539	0.00573	CcSEcCtD
Bleomycin—Haemoglobin—Sorafenib—thyroid cancer	0.000525	0.00559	CcSEcCtD
Bleomycin—Haemorrhage—Sorafenib—thyroid cancer	0.000522	0.00556	CcSEcCtD
Bleomycin—BLMH—Immune System—TPR—thyroid cancer	0.000519	0.00863	CbGpPWpGaD
Bleomycin—BLMH—Immune System—LGALS3—thyroid cancer	0.000515	0.00855	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PRKAR1A—thyroid cancer	0.000511	0.00849	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000501	0.00534	CcSEcCtD
Bleomycin—Paraesthesia—Vandetanib—thyroid cancer	0.000494	0.00526	CcSEcCtD
Bleomycin—Dyspnoea—Vandetanib—thyroid cancer	0.000491	0.00522	CcSEcCtD
Bleomycin—Hyperaesthesia—Epirubicin—thyroid cancer	0.00049	0.00521	CcSEcCtD
Bleomycin—Flushing—Sorafenib—thyroid cancer	0.000485	0.00516	CcSEcCtD
Bleomycin—LIG1—Disease—TRIM24—thyroid cancer	0.00048	0.00796	CbGpPWpGaD
Bleomycin—Decreased appetite—Vandetanib—thyroid cancer	0.000478	0.00509	CcSEcCtD
Bleomycin—Pain—Vandetanib—thyroid cancer	0.00047	0.00501	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—NRG1—thyroid cancer	0.000466	0.00774	CbGpPWpGaD
Bleomycin—Alopecia—Sorafenib—thyroid cancer	0.000462	0.00491	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000455	0.00756	CbGpPWpGaD
Bleomycin—Erythema—Sorafenib—thyroid cancer	0.000455	0.00484	CcSEcCtD
Bleomycin—Hyperaesthesia—Doxorubicin—thyroid cancer	0.000453	0.00482	CcSEcCtD
Bleomycin—LIG1—Disease—CHST14—thyroid cancer	0.000451	0.00749	CbGpPWpGaD
Bleomycin—Extravasation—Epirubicin—thyroid cancer	0.000441	0.00469	CcSEcCtD
Bleomycin—Body temperature increased—Vandetanib—thyroid cancer	0.000435	0.00463	CcSEcCtD
Bleomycin—LIG1—Disease—TRIM33—thyroid cancer	0.000427	0.0071	CbGpPWpGaD
Bleomycin—Anaemia—Sorafenib—thyroid cancer	0.00042	0.00447	CcSEcCtD
Bleomycin—Extravasation—Doxorubicin—thyroid cancer	0.000408	0.00434	CcSEcCtD
Bleomycin—Leukopenia—Sorafenib—thyroid cancer	0.000407	0.00433	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TPR—thyroid cancer	0.000407	0.00676	CbGpPWpGaD
Bleomycin—Ulcer—Epirubicin—thyroid cancer	0.000406	0.00433	CcSEcCtD
Bleomycin—Cough—Sorafenib—thyroid cancer	0.000397	0.00422	CcSEcCtD
Bleomycin—Asthenia—Vandetanib—thyroid cancer	0.000395	0.0042	CcSEcCtD
Bleomycin—Pruritus—Vandetanib—thyroid cancer	0.000389	0.00414	CcSEcCtD
Bleomycin—Myalgia—Sorafenib—thyroid cancer	0.000387	0.00412	CcSEcCtD
Bleomycin—LIG1—S Phase—CCND1—thyroid cancer	0.000377	0.00627	CbGpPWpGaD
Bleomycin—Ulcer—Doxorubicin—thyroid cancer	0.000376	0.004	CcSEcCtD
Bleomycin—Cystitis noninfective—Epirubicin—thyroid cancer	0.000376	0.004	CcSEcCtD
Bleomycin—Cystitis—Epirubicin—thyroid cancer	0.000371	0.00395	CcSEcCtD
Bleomycin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000371	0.00395	CcSEcCtD
Bleomycin—Infection—Sorafenib—thyroid cancer	0.000369	0.00393	CcSEcCtD
Bleomycin—Skin exfoliation—Epirubicin—thyroid cancer	0.000367	0.00391	CcSEcCtD
Bleomycin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000363	0.00387	CcSEcCtD
Bleomycin—Anorexia—Sorafenib—thyroid cancer	0.000354	0.00377	CcSEcCtD
Bleomycin—BLMH—Immune System—CDK1—thyroid cancer	0.000352	0.00584	CbGpPWpGaD
Bleomycin—Vomiting—Vandetanib—thyroid cancer	0.00035	0.00372	CcSEcCtD
Bleomycin—Bladder pain—Epirubicin—thyroid cancer	0.000348	0.0037	CcSEcCtD
Bleomycin—Cystitis noninfective—Doxorubicin—thyroid cancer	0.000347	0.0037	CcSEcCtD
Bleomycin—Rash—Vandetanib—thyroid cancer	0.000347	0.00369	CcSEcCtD
Bleomycin—Dermatitis—Vandetanib—thyroid cancer	0.000347	0.00369	CcSEcCtD
Bleomycin—Cystitis—Doxorubicin—thyroid cancer	0.000343	0.00366	CcSEcCtD
Bleomycin—Skin exfoliation—Doxorubicin—thyroid cancer	0.00034	0.00362	CcSEcCtD
Bleomycin—BLMH—Immune System—IFNA2—thyroid cancer	0.000338	0.00562	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000338	0.0036	CcSEcCtD
Bleomycin—Dyspnoea—Sorafenib—thyroid cancer	0.000331	0.00352	CcSEcCtD
Bleomycin—Nausea—Vandetanib—thyroid cancer	0.000327	0.00348	CcSEcCtD
Bleomycin—Phlebitis—Epirubicin—thyroid cancer	0.000324	0.00345	CcSEcCtD
Bleomycin—Decreased appetite—Sorafenib—thyroid cancer	0.000323	0.00343	CcSEcCtD
Bleomycin—Bladder pain—Doxorubicin—thyroid cancer	0.000322	0.00342	CcSEcCtD
Bleomycin—Pain—Sorafenib—thyroid cancer	0.000317	0.00338	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000308	0.00512	CbGpPWpGaD
Bleomycin—Phlebitis—Doxorubicin—thyroid cancer	0.0003	0.00319	CcSEcCtD
Bleomycin—Urticaria—Sorafenib—thyroid cancer	0.000295	0.00314	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000294	0.00488	CbGpPWpGaD
Bleomycin—Body temperature increased—Sorafenib—thyroid cancer	0.000293	0.00312	CcSEcCtD
Bleomycin—LIG1—Disease—TCF7L1—thyroid cancer	0.000285	0.00474	CbGpPWpGaD
Bleomycin—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000285	0.00303	CcSEcCtD
Bleomycin—BLMH—Immune System—NRG1—thyroid cancer	0.000283	0.00469	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDK1—thyroid cancer	0.000276	0.00458	CbGpPWpGaD
Bleomycin—Hypersensitivity—Sorafenib—thyroid cancer	0.000273	0.00291	CcSEcCtD
Bleomycin—Asthenia—Sorafenib—thyroid cancer	0.000266	0.00283	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000265	0.00441	CbGpPWpGaD
Bleomycin—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000264	0.00281	CcSEcCtD
Bleomycin—Pruritus—Sorafenib—thyroid cancer	0.000263	0.0028	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000256	0.00425	CbGpPWpGaD
Bleomycin—Vomiting—Sorafenib—thyroid cancer	0.000236	0.00251	CcSEcCtD
Bleomycin—Rash—Sorafenib—thyroid cancer	0.000234	0.00249	CcSEcCtD
Bleomycin—Dermatitis—Sorafenib—thyroid cancer	0.000234	0.00249	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PTEN—thyroid cancer	0.000233	0.00387	CbGpPWpGaD
Bleomycin—Pancytopenia—Epirubicin—thyroid cancer	0.000229	0.00244	CcSEcCtD
Bleomycin—Nausea—Sorafenib—thyroid cancer	0.00022	0.00235	CcSEcCtD
Bleomycin—Weight decreased—Epirubicin—thyroid cancer	0.000218	0.00232	CcSEcCtD
Bleomycin—Pneumonia—Epirubicin—thyroid cancer	0.000216	0.0023	CcSEcCtD
Bleomycin—Pancytopenia—Doxorubicin—thyroid cancer	0.000212	0.00226	CcSEcCtD
Bleomycin—Stomatitis—Epirubicin—thyroid cancer	0.00021	0.00223	CcSEcCtD
Bleomycin—LIG1—Disease—TPR—thyroid cancer	0.000209	0.00347	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—NRAS—thyroid cancer	0.000208	0.00346	CbGpPWpGaD
Bleomycin—LIG1—Disease—PRKAR1A—thyroid cancer	0.000205	0.00341	CbGpPWpGaD
Bleomycin—Haematuria—Epirubicin—thyroid cancer	0.000205	0.00218	CcSEcCtD
Bleomycin—Weight decreased—Doxorubicin—thyroid cancer	0.000202	0.00215	CcSEcCtD
Bleomycin—Pneumonia—Doxorubicin—thyroid cancer	0.0002	0.00213	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TERT—thyroid cancer	0.000199	0.0033	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000197	0.00327	CbGpPWpGaD
Bleomycin—LIG1—Disease—MEN1—thyroid cancer	0.000196	0.00326	CbGpPWpGaD
Bleomycin—Haemoglobin—Epirubicin—thyroid cancer	0.000194	0.00207	CcSEcCtD
Bleomycin—Stomatitis—Doxorubicin—thyroid cancer	0.000194	0.00206	CcSEcCtD
Bleomycin—Haemorrhage—Epirubicin—thyroid cancer	0.000193	0.00206	CcSEcCtD
Bleomycin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000192	0.00204	CcSEcCtD
Bleomycin—Haematuria—Doxorubicin—thyroid cancer	0.00019	0.00202	CcSEcCtD
Bleomycin—Haemoglobin—Doxorubicin—thyroid cancer	0.00018	0.00191	CcSEcCtD
Bleomycin—Flushing—Epirubicin—thyroid cancer	0.000179	0.00191	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—KRAS—thyroid cancer	0.000179	0.00298	CbGpPWpGaD
Bleomycin—Haemorrhage—Doxorubicin—thyroid cancer	0.000179	0.0019	CcSEcCtD
Bleomycin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000178	0.00189	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000175	0.0029	CbGpPWpGaD
Bleomycin—Chills—Epirubicin—thyroid cancer	0.000173	0.00184	CcSEcCtD
Bleomycin—Alopecia—Epirubicin—thyroid cancer	0.000171	0.00182	CcSEcCtD
Bleomycin—Erythema—Epirubicin—thyroid cancer	0.000168	0.00179	CcSEcCtD
Bleomycin—Flushing—Doxorubicin—thyroid cancer	0.000166	0.00176	CcSEcCtD
Bleomycin—Chills—Doxorubicin—thyroid cancer	0.00016	0.00171	CcSEcCtD
Bleomycin—Alopecia—Doxorubicin—thyroid cancer	0.000158	0.00168	CcSEcCtD
Bleomycin—LIG1—Disease—CALCA—thyroid cancer	0.000156	0.00259	CbGpPWpGaD
Bleomycin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000156	0.00166	CcSEcCtD
Bleomycin—Erythema—Doxorubicin—thyroid cancer	0.000156	0.00166	CcSEcCtD
Bleomycin—Anaemia—Epirubicin—thyroid cancer	0.000155	0.00165	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—HRAS—thyroid cancer	0.000152	0.00253	CbGpPWpGaD
Bleomycin—Malaise—Epirubicin—thyroid cancer	0.000152	0.00161	CcSEcCtD
Bleomycin—Leukopenia—Epirubicin—thyroid cancer	0.00015	0.0016	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000148	0.00245	CbGpPWpGaD
Bleomycin—Cough—Epirubicin—thyroid cancer	0.000147	0.00156	CcSEcCtD
Bleomycin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000144	0.00154	CcSEcCtD
Bleomycin—Anaemia—Doxorubicin—thyroid cancer	0.000144	0.00153	CcSEcCtD
Bleomycin—Chest pain—Epirubicin—thyroid cancer	0.000143	0.00152	CcSEcCtD
Bleomycin—Myalgia—Epirubicin—thyroid cancer	0.000143	0.00152	CcSEcCtD
Bleomycin—BLMH—Immune System—PTEN—thyroid cancer	0.000142	0.00235	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDK1—thyroid cancer	0.000141	0.00235	CbGpPWpGaD
Bleomycin—Discomfort—Epirubicin—thyroid cancer	0.000141	0.0015	CcSEcCtD
Bleomycin—Malaise—Doxorubicin—thyroid cancer	0.00014	0.00149	CcSEcCtD
Bleomycin—Leukopenia—Doxorubicin—thyroid cancer	0.000139	0.00148	CcSEcCtD
Bleomycin—Confusional state—Epirubicin—thyroid cancer	0.000138	0.00147	CcSEcCtD
Bleomycin—Oedema—Epirubicin—thyroid cancer	0.000137	0.00146	CcSEcCtD
Bleomycin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000137	0.00146	CcSEcCtD
Bleomycin—Infection—Epirubicin—thyroid cancer	0.000136	0.00145	CcSEcCtD
Bleomycin—Cough—Doxorubicin—thyroid cancer	0.000136	0.00144	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—AKT1—thyroid cancer	0.000134	0.00223	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000134	0.00143	CcSEcCtD
Bleomycin—Myalgia—Doxorubicin—thyroid cancer	0.000132	0.00141	CcSEcCtD
Bleomycin—Chest pain—Doxorubicin—thyroid cancer	0.000132	0.00141	CcSEcCtD
Bleomycin—Discomfort—Doxorubicin—thyroid cancer	0.000131	0.00139	CcSEcCtD
Bleomycin—Anorexia—Epirubicin—thyroid cancer	0.000131	0.00139	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.000128	0.00213	CbGpPWpGaD
Bleomycin—Hypotension—Epirubicin—thyroid cancer	0.000128	0.00136	CcSEcCtD
Bleomycin—Confusional state—Doxorubicin—thyroid cancer	0.000128	0.00136	CcSEcCtD
Bleomycin—Oedema—Doxorubicin—thyroid cancer	0.000127	0.00135	CcSEcCtD
Bleomycin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000127	0.00135	CcSEcCtD
Bleomycin—BLMH—Immune System—NRAS—thyroid cancer	0.000126	0.0021	CbGpPWpGaD
Bleomycin—Infection—Doxorubicin—thyroid cancer	0.000126	0.00134	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000125	0.00133	CcSEcCtD
Bleomycin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000124	0.00132	CcSEcCtD
Bleomycin—Paraesthesia—Epirubicin—thyroid cancer	0.000123	0.00131	CcSEcCtD
Bleomycin—Dyspnoea—Epirubicin—thyroid cancer	0.000122	0.0013	CcSEcCtD
Bleomycin—Anorexia—Doxorubicin—thyroid cancer	0.000121	0.00129	CcSEcCtD
Bleomycin—Decreased appetite—Epirubicin—thyroid cancer	0.000119	0.00127	CcSEcCtD
Bleomycin—Hypotension—Doxorubicin—thyroid cancer	0.000119	0.00126	CcSEcCtD
Bleomycin—Pain—Epirubicin—thyroid cancer	0.000117	0.00125	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000116	0.00123	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CCND1—thyroid cancer	0.000115	0.00191	CbGpPWpGaD
Bleomycin—Paraesthesia—Doxorubicin—thyroid cancer	0.000114	0.00121	CcSEcCtD
Bleomycin—LIG1—Disease—NRG1—thyroid cancer	0.000114	0.00189	CbGpPWpGaD
Bleomycin—Dyspnoea—Doxorubicin—thyroid cancer	0.000113	0.0012	CcSEcCtD
Bleomycin—Feeling abnormal—Epirubicin—thyroid cancer	0.000113	0.0012	CcSEcCtD
Bleomycin—Decreased appetite—Doxorubicin—thyroid cancer	0.00011	0.00117	CcSEcCtD
Bleomycin—Urticaria—Epirubicin—thyroid cancer	0.000109	0.00116	CcSEcCtD
Bleomycin—BLMH—Immune System—KRAS—thyroid cancer	0.000109	0.0018	CbGpPWpGaD
Bleomycin—Pain—Doxorubicin—thyroid cancer	0.000109	0.00116	CcSEcCtD
Bleomycin—Body temperature increased—Epirubicin—thyroid cancer	0.000108	0.00115	CcSEcCtD
Bleomycin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000105	0.00111	CcSEcCtD
Bleomycin—LIG1—Disease—TERT—thyroid cancer	0.000102	0.00169	CbGpPWpGaD
Bleomycin—Hypersensitivity—Epirubicin—thyroid cancer	0.000101	0.00108	CcSEcCtD
Bleomycin—Urticaria—Doxorubicin—thyroid cancer	0.000101	0.00107	CcSEcCtD
Bleomycin—Body temperature increased—Doxorubicin—thyroid cancer	0.0001	0.00107	CcSEcCtD
Bleomycin—Asthenia—Epirubicin—thyroid cancer	9.84e-05	0.00105	CcSEcCtD
Bleomycin—LIG1—Disease—HIF1A—thyroid cancer	9.75e-05	0.00162	CbGpPWpGaD
Bleomycin—Pruritus—Epirubicin—thyroid cancer	9.7e-05	0.00103	CcSEcCtD
Bleomycin—Hypersensitivity—Doxorubicin—thyroid cancer	9.35e-05	0.000995	CcSEcCtD
Bleomycin—BLMH—Immune System—HRAS—thyroid cancer	9.24e-05	0.00153	CbGpPWpGaD
Bleomycin—Asthenia—Doxorubicin—thyroid cancer	9.11e-05	0.000969	CcSEcCtD
Bleomycin—Pruritus—Doxorubicin—thyroid cancer	8.98e-05	0.000956	CcSEcCtD
Bleomycin—Vomiting—Epirubicin—thyroid cancer	8.72e-05	0.000928	CcSEcCtD
Bleomycin—Rash—Epirubicin—thyroid cancer	8.65e-05	0.000921	CcSEcCtD
Bleomycin—Dermatitis—Epirubicin—thyroid cancer	8.64e-05	0.00092	CcSEcCtD
Bleomycin—BLMH—Immune System—AKT1—thyroid cancer	8.15e-05	0.00135	CbGpPWpGaD
Bleomycin—Nausea—Epirubicin—thyroid cancer	8.15e-05	0.000867	CcSEcCtD
Bleomycin—LIG1—Disease—BRAF—thyroid cancer	8.07e-05	0.00134	CbGpPWpGaD
Bleomycin—Vomiting—Doxorubicin—thyroid cancer	8.07e-05	0.000859	CcSEcCtD
Bleomycin—Rash—Doxorubicin—thyroid cancer	8e-05	0.000852	CcSEcCtD
Bleomycin—Dermatitis—Doxorubicin—thyroid cancer	7.99e-05	0.000851	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TP53—thyroid cancer	7.57e-05	0.00126	CbGpPWpGaD
Bleomycin—Nausea—Doxorubicin—thyroid cancer	7.54e-05	0.000803	CcSEcCtD
Bleomycin—LIG1—Disease—PTGS2—thyroid cancer	6.52e-05	0.00108	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTEN—thyroid cancer	5.69e-05	0.000944	CbGpPWpGaD
Bleomycin—LIG1—Disease—NRAS—thyroid cancer	5.07e-05	0.000843	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—thyroid cancer	4.37e-05	0.000725	CbGpPWpGaD
Bleomycin—LIG1—Disease—HRAS—thyroid cancer	3.71e-05	0.000616	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKT1—thyroid cancer	3.28e-05	0.000544	CbGpPWpGaD
